Address correspondence to Dr Jon Stone, Department of Clinical Neuroscience, Western General Hospital, Edinburgh, UK EH4 2XU, email@example.com.
Relationship Disclosure: Dr Stone receives personal compensation for expert testimony related to personal injury and negligence cases from multiple UK law firms and receives royalties from UpToDate, Inc. Dr Stone has received honoraria for lectures from the British Medical Association and Novartis AG and travel compensation from the European Neurological Society, Movement Disorders Society, Royal College of Psychiatrists, and from neurology departments in Amsterdam, Cork, Leuven, Oxford, Reykjavík, and St Louis.
Dr Carson receives personal compensation for expert testimony related to personal injury and negligence cases and has received honoraria for lectures from Novartis AG and UCB, Inc. Dr Carson serves as associate editor of the Journal of Neurology, Neurosurgery, and Psychiatry, serves as president of the executive committee of The British NeuroPsychiatry Association, and receives book royalties from BMJ Books.
Unlabeled Use of Products/Investigational Use Disclosure: Drs Stone and Carson discuss the unlabeled/investigational use of antidepressant medication and transcranial magnetic stimulation for treating functional disorders.
Supplemental digital content: Videos accompanying this article are cited in the text as Supplemental Digital Content. Videos may be accessed by clicking on links provided in the HTML, PDF, and app versions of this article; the URLs are provided in the print version. Video legends begin on page 833.